Hjem › Nyrekreft (nyrecellekarcinom) › Texas › Dallas
Kliniske studier for Nyrekreft (nyrecellekarcinom) i Dallas, TX
23 studier for Nyrekreft (nyrecellekarcinom) søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RekruttererFase 1
- NEO-811 Dallas Site, Dallas
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RekruttererFase 1
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #89, Dallas
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
- Research Site, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
- Baylor, Scott and White Research Institute, Dallas
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RekruttererFase 2
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekruttererFase 1/2
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- og 2 flere
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
RekruttererFase 2
- University of Texas Southwestern Medical Center, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- UT Southwestern Medical Center, Dallas
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
RekruttererFase 1/2
- Mary Crowley Cancer Research, Dallas
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RekruttererFase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
RekruttererFase 2
- University of Texas, Southwestern Medical Center, Dallas
PET/MR for Characterization of Renal Masses (RMs)
RekruttererObservasjonsstudie
- University of Texas Southwestern Medical Center, Dallas
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekruttererFase 1
- UT Southwestern Simmons Cancer Center, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruttererFase 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
RekruttererFase 2
- UT Southwestern Medical Center, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
RekruttererFase 1
- Mary Crowley Cancer Research, Dallas
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
RekruttererFrivillige helsepersonell ønskes velkommen
- University of Texas Southwestern Medical Center, Dallas
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
RekruttererFase 1
- UT Southwestern Medical Center, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
RekruttererFase 2
- University of Texas Southwestern Medical Center, Dallas
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
RekruttererFase 2
- UT Southwestern Medical Center, Dallas
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RekruttererFase 3
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Nyrekreft (nyrecellekarcinom)-studier i andre byer
- Houston, TX35 studier
- New York City, NY27 studier
- Nashville, TN23 studier
- St. Louis, MO23 studier
- Los Angeles, CA20 studier
- Boston, MA16 studier
- Baldwin Park, CA16 studier
- Philadelphia, PA15 studier
- Pittsburgh, PA15 studier
- Queens, NY15 studier
- Rochester, MN14 studier
- Cleveland, OH14 studier
Andre studier i Dallas
- Brystkreft55 studier
- Ikke-småcellet lungekreft52 studier
- Metastatisk kreft42 studier
- Hjertesvikt42 studier
- Kreft (alle typer)37 studier
- Prostatakreft36 studier
- Kolorektal kreft33 studier
- Fedme30 studier
- Eggstokkreft28 studier
- Lungekreft27 studier
- Blærekreft27 studier
- Endometriekreft24 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.